United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mawdsley-brooks & company ltd - erythromycin - gastro-resistant tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

genesis pharmaceuticals ltd - erythromycin - gastro-resistant tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen pharma ltd - erythromycin - gastro-resistant tablet - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

noumed life sciences ltd - erythromycin - gastro-resistant tablet - 250mg

United Kingdom - English - myHealthbox

milpharm limited - erythromycin ethylsuccinate - granules for oral suspension - 125mg/5ml - for the prophylaxis and treatment of infections caused by erythromycin sensitive organisms and in the treatment of a great variety of clinical infections

United Kingdom - English - myHealthbox

milpharm limited - erythromycin ethylsuccinate - granules for oral suspension - 250mg/5ml - for the prophylaxis and treatment of infections caused by erythromycin sensitive organisms and in the treatment of a great variety of clinical infections

United Kingdom - English - myHealthbox

milpharm limited - erythromycin ethylsuccinate - granules for oral suspension - 500mg/5ml - for the prophylaxis and treatment of infections caused by erythromycin sensitive organisms. erythromycin is highly effective in the treatment of a great variety of clinical infections

Australia - English - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - erythromycin lactobionate, quantity: 1.4882 g/g (equivalent: erythromycin, qty 1 g) - injection, powder for - excipient ingredients: - oral erythromycin is not considered to be the antibiotic of choice in severely ill patients.,erythromycin-link (sterile erythromycin lactobionate) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below when oral administration is not possible or when the severity of the infection requires immediate high serum levels of erythromycin. intravenous therapy should be replaced by oral administration at the appropriate time.,? upper respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae); haemophilus influenzae (many strains of h. influenzae are not susceptible to the erythromycin concentrations ordinarily achieved).,? lower respiratory tract infections caused by streptococcus pyogenes (group a beta-haemolytic streptococci); streptococcus pneumoniae (diplococcus pneumoniae).,? respiratory tract infections due to mycoplasma pneumoniae.,? skin and s

Canada - English - Health Canada

pro doc limitee - erythromycin stearate - tablet - 250mg - erythromycin stearate 250mg - erythromycins

Canada - English - Health Canada

laboratoires confab inc - erythromycin - capsule - 250mg - erythromycin 250mg - erythromycins